Table 1 Characteristics of included studies
Study | Year | Region | Design | Group | N | Age (day)* | Weight (kg)* | Ventricle physiology (SV/DV, n) | Cardiac anomaly | Conduit size (mm)* | Device manufacturer | Follow up (year)* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Santoro [16] | 2009 | Italy | RC | Stent | 13 | 22 ± 39 | 3.2 ± 0.9 | NA | TOF = 2, PAIVS = 6, others = 5 | 3.3 ± 0.4 | Medtronic | 0.6 ± 0.3 |
Shunt | 14 | 21 ± 30 | 3.3 ± 1.2 | NA | TOF = 6, PAIVS = 2, others = 6 | 4.4 ± 0.3 | Gore-Tex | 1 ± 0.5 | ||||
Amoozgar [17] | 2012 | Iran | RC | Stent | 15 | 56 ± 60.2 | 3.9 ± 2.5 | 4/11 | TOF = 2, PA = 10, TA = 2, TGA = 1 | 3.8 ± 0.3 | Boston, Skylor, Blazer, Abbott | 0.5 |
Shunt | 20 | 102.5 ± 81 | 5 ± 1.6 | 5/15 | TOF = 4, PA = 9, TA = 3, DORV = 1, others = 3 | NA | NA | 0.5 | ||||
McMullan [18] | 2014 | USA | RC | Stent | 13 | 18.3 ± 15.4 | 3.3 ± 2.0 | 2/11 | TOF = 1, PA = 8, TGA = 2, others = 2 | NA | Abbott | 0.5 (0–1) |
Shunt | 42 | 12 ± 54 | 3.3 ± 1.6 | 5/37 | TOF = 7, DORV = 7, PA = 12, TA = 4, TGA = 8, others = 4 | NA | Gore-Tex | 0.5 (0–1) | ||||
Mallula [19] | 2015 | USA | RC | Stent | 13 | 7.3 ± 5.3 | 3.3 ± 0.4 | 0/9 | PAIVS = 13 | 3.5 ± 0 | Boston, Medtronic, Abbott | 2 (0.1–6) |
Shunt | 16 | 10 ± 6.5 | 2.9 ± 0.5 | 8/5 | PAIVS = 16 | 3.5 ± 0.3 | NA | 2.5 (0.3–8.5) | ||||
Glatz [20] | 2018 | USA | RC | Stent | 106 | 9 ± 1.7 | 3.2 ± 0.2 | 42/64 | PAIVS = 47, PAVSD = 18, TA = 5, PS = 36 | NA | NA | NA |
Shunt | 251 | 6 ± 1.8 | 3.1 ± 0.1 | 139/112 | PAIVS = 50, PS = 63, PAVSD = 99, TA = 39 | NA | NA | NA | ||||
Bentham [21] | 2018 | UK | RC | Stent | 83 | 8 ± 1.5 | 3.1 ± 0.1 | 37/44 | TOF = 6, PAIVS = 23, PAVSD = 22, DORV = 6, TA = 6, TGA = 15, others = 5 | 3.8 ± 0.3 | NA | 1 |
Shunt | 171 | 8 ± 1.7 | 3.1 ± 0.1 | 82/74 | TOF = 18, PAIVS = 32, PAVSD = 31, DORV = 17, TA = 17, TGA = 24, others = 32 | 3.6 ± 0.2 | Gore-Tex | 1 |